Asymmetric-interfacial nanofibrous membranes with diode-like exudate transport for nanozyme-catalyzed antibacterial wound healing.
The study presents a novel wound dressing that achieved 99.8% closure in a murine model of antibiotic-resistant infection, but its applicability to human wounds is not yet established.
Where it sits
this study against the rest of the ghk-cu corpusSummary and findings
This study investigates asymmetric-interfacial Janus nanofibrous membranes for antibacterial wound healing in a murine model. The dressing achieved 99.8% wound closure by day 12 in infected wounds. The study highlights the membrane's ability to reduce bacterial burden and enhance healing without specific therapeutic claims.
Abstract
Antibiotic-resistant wound infections require dressings that rapidly remove protein-rich exudate, resist fouling and bacterial adhesion, and provide drug-sparing antimicrobial activity. Here we develop asymmetric-interfacial Janus nanofibrous membranes that integrate diode-like exudate transport with infection-microenvironment-responsive nanozyme catalysis for antibacterial wound healing. The membrane couples a multiscale-rough superhydrophobic outer layer with a hydrophilic inner layer, establishing a through-thickness wettability gradient and capillary-pressure asymmetry that preferentially pumps liquids from the hydrophilic side to the superhydrophobic side while suppressing reverse wetting. An asymmetric Janus nanofibrous membrane (Janus-ZnCu-BIF NFM), composed of a hydrophilic nanofiber layer selectively loaded with copper-doped zinc boron imidazolate framework (ZnCu-BIF) nanocubes and an integrated hydrophobic polylactic acid layer, exhibits catalytic antibacterial activity by promoting reactive oxygen species generation and disrupting bacterial membrane integrity. The resulting membrane nearly eliminated viable multidrug-resistant bacteria in vitro. In a murine full-thickness wound model infected with methicillin-resistant Staphylococcus aureus, the dressing significantly reduced bacterial burden and accelerated healing, reaching 99.8% wound closure by day 12. Histological analyses indicated attenuated inflammation, enhanced angiogenesis, and improved dermal regeneration, while transcriptomic profiling revealed enrichment of pathways associated with extracellular-matrix remodeling and vascular development. Overall, this work establishes a scalable, biomimetic dressing that couples rectified exudate management with robust catalytic antibacterial efficacy, providing a practical route toward next-generation wound care materials for drug-resistant infections.
Background
This paper addresses the challenge of antibiotic-resistant wound infections, which necessitate advanced dressing materials that can effectively manage exudate and provide antimicrobial properties. Previous studies have highlighted the limitations of conventional dressings in these contexts. This research introduces a novel asymmetric-interfacial Janus nanofibrous membrane designed to enhance wound healing through innovative transport and catalytic mechanisms.
Methods
The study employed a murine full-thickness wound model with n not reported in abstract. The asymmetric Janus nanofibrous membrane was composed of a hydrophilic layer loaded with ZnCu-BIF nanocubes and a hydrophobic polylactic acid layer. Primary outcomes included bacterial burden reduction and wound closure percentage over a 12-day period.
Results
The primary endpoint showed 99.8% wound closure by day 12. The dressing significantly reduced bacterial burden, although specific numeric reductions were not reported in abstract. Histological analyses indicated enhanced angiogenesis and improved dermal regeneration.
Interpretation
The findings suggest that the Janus nanofibrous membrane may offer a promising approach to wound care, particularly for drug-resistant infections. However, while the effect size appears statistically significant, its clinical relevance in human populations remains uncertain. The use of a murine model introduces confounding factors that may limit the generalizability of the results.
Key findings
- 99.8% wound closure by day 12 in murine model infected with methicillin-resistant Staphylococcus aureus.
- Nearly eliminated viable multidrug-resistant bacteria in vitro.
- Histological analyses indicated enhanced angiogenesis and improved dermal regeneration.
Limitations
- murine model may not fully translate to humans
- long-term effects not assessed
- small sample size not reported
- specific bacterial burden reductions not reported